Roche
RO.SW
#43
Rank
NZ$602.17 B
Marketcap
NZ$755.78
Share price
-1.63%
Change (1 day)
42.22%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$34.72

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$34.72. In 2025 the company made an earnings per share (EPS) of NZ$34.72 an increase over its 2024 EPS that were of NZ$19.54.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$34.7277.67%
2024NZ$19.54-32.84%
2023NZ$29.091.95%
2022NZ$28.54-6.29%
2021NZ$30.45-5.53%
2020NZ$32.2416.56%
2019NZ$27.6630.3%
2018NZ$21.2320.22%
2017NZ$17.65-5.81%
2016NZ$18.744.62%
2015NZ$17.92-5.13%
2014NZ$18.89-25.05%
2013NZ$25.2021.73%
2012NZ$20.703.82%
2011NZ$19.948.16%
2010NZ$18.4323.72%
2009NZ$14.90-12.31%
2008NZ$16.99-0.34%
2007NZ$17.0532.13%
2006NZ$12.9042.56%
2005NZ$9.05-22.7%
2004NZ$11.71132.85%
2003NZ$5.03-150.5%
2002NZ-$9.96-209.09%
2001NZ$9.13-57.03%
2000NZ$21.2453.29%
1999NZ$13.8531.24%
1998NZ$10.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.84-57.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.92-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.13-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.60-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.35-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$5.61-83.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.07-82.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.60-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK